Source comparison
SS-31 vs MOTS-C: Research Protocols and Reconstitution
Understanding the SS-31 vs MOTS-C protocols requires appreciating that both peptides are water-soluble and reconstituted similarly, but differ in dosing schedules used in published preclinical studies. For SS-31 research, published protocols have typically use
This comparison does not assign a generated winner or score.
- Understanding the SS-31 vs MOTS-C protocols requires appreciating that both peptides are water-soluble and reconstituted similarly, but differ in dosing schedules used in published preclinical studies. For SS-31 research, published protocols have typically used 3–5 mg/kg subcutaneous daily injections in rodent models. Reconstitution uses bacteriostatic water (0.9% benzyl alcohol) at a standard concentration of 1 mg/mL, yielding a clear solution.
- Storage of reconstituted SS-31 is typically at 4°C for short-term use (up to 4 weeks) or −20°C for longer-term storage. Lyophilized SS-31 peptide powder is stable at room temperature when sealed, but should be stored at −20°C for extended shelf life.
- For MOTS-C research protocols, the published literature commonly reports doses of 0.5–5 mg/kg in rodent models. Reconstitution follows the same bacteriostatic water protocol: add sterile bacteriostatic water slowly to the lyophilized powder, swirl gently without vigorous agitation to avoid degrading the peptide structure. A common research concentration is 1 mg/mL.
- MOTS-C is typically dosed 3–5 times per week in published metabolic studies rather than daily. Both peptides should be inspected for particulate matter and discoloration before use; any turbid or discolored solution should be discarded. Researchers should review the peptide reconstitution guide for detailed protocol steps, and the peptide storage guide for best practices on maintaining compound stability.